DermTech, Inc.
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expr…
Medical - Diagnostics & Research
US, La Jolla [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
DermTech, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDDermTech, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of DermTech, Inc..
If you want to see a demo, head over to the financial segments of AAPL